about
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide.Macroporous modified poly (vinyl alcohol) hydrogels with charged groups for tissue engineering: Preparation and in vitro evaluation.3D in vitro co-culture models based on normal cells and tumor spheroids formed by cyclic RGD-peptide induced cell self-assembly.Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size.Ultrasonically Assisted Polysaccharide Microcontainers for Delivery of Lipophilic Antitumor Drugs: Preparation and in Vitro Evaluation.Microfluidic conceived pH sensitive core-shell particles for dual drug delivery.Microfluidic conceived drug loaded Janus particles in side-by-side capillaries device.Sialylation transmogrifies human breast and pancreatic cancer cells into 3D multicellular tumor spheroids using cyclic RGD-peptide induced self-assembly.Multicellular tumor spheroids in microcapsules as a novel 3D in vitro model in tumor biology.Novel Doxorubicin Derivatives: Synthesis and Cytotoxicity Study in 2D and 3D in Vitro Models.Biodistribution of X-Ray Iodinated Contrast Agent in Nano-Emulsions Is Controlled by the Chemical Nature of the Oily CoreFunctionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner CoreMetformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cellsPhotodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotideIn situ preparation of gold-polyester nanoparticles for biomedical imaging
P50
Q33650423-EC7874F5-5309-4E1D-A486-53C499955433Q38707374-B527003C-3DEA-4303-8230-AFA1E89A3B0BQ38744260-9D33046F-CA1E-436E-B6F1-D802E61B55C3Q38775996-662CEA63-AE71-4FB4-954D-BC1009A2CC6DQ38824053-F4BE65FD-17AA-48D3-8BF5-8EB4DA119D61Q38855128-A5E20FC2-AF15-4EA2-BD64-79CBE0CC5851Q38948678-3BBDD217-2A10-434B-9D35-397E01BCC52AQ38982145-F3B7E736-2D62-4F17-A565-2EB48A6CE808Q41960794-62AEECB3-4724-4298-AD11-B741E6F51F04Q46421664-C38877C5-3AA7-4290-9A88-700246BC386FQ49240708-A084BE79-A0E1-4AEB-81FB-D31FCDA6F622Q58209010-4A9F137B-0C22-409F-A59E-A4315537872AQ58802900-DEC2EBF5-ACC5-41A2-B1A0-E24AEB8637C2Q90513693-FF63E490-ED2E-4EA3-AD57-276002BC1181Q91622718-082E0CAA-15FB-42C1-B248-5B13737CAE59Q92110682-A182C489-51EC-4409-A93F-DF4EDB043558
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Roman Akasov
@ast
Roman Akasov
@en
Roman Akasov
@es
Roman Akasov
@nl
type
label
Roman Akasov
@ast
Roman Akasov
@en
Roman Akasov
@es
Roman Akasov
@nl
prefLabel
Roman Akasov
@ast
Roman Akasov
@en
Roman Akasov
@es
Roman Akasov
@nl
P106
P1153
56285575900
P31
P496
0000-0001-6486-8114